Comparing Standard Platelet-Rich Plasma and Light-Enhanced Platelet-Rich Plasma for Treating Hair Loss in Androgenetic Alopecia: A Randomized Controlled Trial

The goal of this clinical trial is to compare 3 different types of PRP in androgenetic alopecia patients. The main questions it aims to answer: Does Redlight enhanced, Blue light enhanced, or traditional PRP result in higher hair density and health? Does Redlight enhanced, Blue light enhanced, or traditional PRP result in other improved hair metrics. Participants will consent to a PRP treatment but will be blinded to the type. They will then be asked to return for Tricholab analysis at set post-operative timepoints to record changes in hair metrics (Baseline, 1 month, 3 months, 6 months, 9 months, 12 months).

Inclusion Criteria: * Age 18-65 * Diagnosed Androgenetic Alopecia * Willing to comply with protocol and follow up Exclusion Criteria: * Active scalp infection or disease * Prior PRP within last 6 months * Use of hair growth medication topical or oral * Platelet dysfunction or anticoagulation * Pregnant or breastfeeding * history of keloid infection